A 5-SKU cosmeceutical skincare packaging design, built on the Jarsking oblong capsule glass bottle and jar platform.
DERMIS//01 is a full-concept packaging development project by Jarsking — a working demonstration of how a science-led skincare brand can be conceived, structured, and packaged as a coherent, retail-ready clinical system, from brand philosophy to bottle specification to social-content deployment. Every element shown here — the pharmaceutical-capsule silhouette, the frosted-glass-and-graphite material story, the five-step product hierarchy, the gift-set architecture — was developed on Jarsking’s own glass capsule platform, with real manufacturing logic behind every creative decision.
The concept answers a measurable market shift. The global cosmeceuticals market is estimated at roughly USD 80–100 billion in 2025, and the doctor-recommended, clinically-positioned tier is one of its fastest-growing segments at close to 9% CAGR — driven by consumers who cross-reference product claims with dermatology research before they buy. DERMIS//01 packages that buyer’s worldview: precision, evidence, restraint.
The name does the first layer of work before a single ingredient is read. Dermis is the correct anatomical term for the skin’s primary functional layer; 01 signals a system designed with sequenced, numbered logic rather than aesthetic whim. Together they communicate medical legitimacy at a glance — the exact cue the modern skincare buyer is scanning for.
That buyer is real and well-documented. They read the clinical study before the serum, know the difference between AHA and BHA, and will invest USD 80+ in a single product when the formulation logic holds — but they are resistant to gimmick packaging and respond to transparency, precision, and restraint. The packaging system is engineered for exactly this reader: every panel rewards close inspection, and nothing shouts. For a brand, that is not a mood — it is a conversion strategy aimed at a high-intent, high-LTV customer.
Positioning is a packaging brief, not a slogan. DERMIS//01 sits at the accessible clinical-premium tier — benchmarked against Medik8, SkinCeuticals, Paula’s Choice, Dr. Barbara Sturm, and Augustinus Bader — and targets two buyers at once: the Informed Optimizer (28–45, urban, data-literate, DTC-first) and the Clinic-Referred Patient (35–60, sent home after a laser, peel, or injectable to protect a clinical investment).
Both buyers reward a medical visual code and punish theatrical beauty packaging. So the design system removes warmth from the typography and the surface, and relocates it to two places only: the graphite cap and the formula color seen through frosted glass. The result reads as a lab instrument that happens to be beautiful — credibility first, desire second. That sequence is what lets a clinical brand command premium price and earn the clinic channel’s trust.
The structural backbone of the concept is the Jarsking oblong capsule glass bottle. Its silhouette is not incidentally clinical — it is the exact form of a pharmaceutical capsule rendered at industrial scale. In frosted, thick-base glass with a warm-graphite injection-molded cap, it reads simultaneously as a laboratory instrument and a luxury object.
The horizontal ribbing on the capsule body becomes a proprietary brand asset. Read in a clinical-imaging context, the ribs scan as ultrasound lines, MRI cross-sections, or the grid of a dermatoscope — referenced in the brand’s visual language as “frequency lines,” the structural frequency at which the skin is being corrected. A distinctive, ownable silhouette is a commercial advantage: it is recognizable on a shelf, in a 200-pixel thumbnail, and in a competitor-crowded search result.
The art direction strips out color distraction and leaves a stark interplay of bone-white and cool-gray, viewed as if through X-ray vision: an empty laboratory bench, surgical steel, electron-microscope texture, molecular bond line-art, pharmaceutical grid paper. The discipline is the point. A single, tightly defined visual register makes every downstream asset — PDP, flat-lay, story frame, retail display — look like it belongs to one system.
There is a hard commercial dividend to that consistency. In social-led skincare, packaging is the product’s first advertisement, and a coherent visual identity dramatically lowers the cost and time of producing on-brand content at volume.
| Element | Color | Finish |
|---|---|---|
| Glass body | pearlescent white (other option: frosted clear) | Acid-etch or sand-blast texture |
| Pump cap / jar cap | Warm graphite / matte silver | Matte rubber-touch injection |
| Silk-screen print | Bone white or cool platinum | Single color, 2 colors maximum |
| Step numbers | Bone white, 3× tracking | Ultra-legible on frosted glass |
| Formula color (through glass) | Varies by SKU | Natural, unpigmented |
The palette is deliberately mono: a graphite-and-bone system with no decorative warmth.
Five SKUs, graduated across four bottle heights and one jar, create a compact, complete skin system that displays with architectural coherence — on a bathroom shelf, a clinic counter, or a DTC landing-page flat-lay.
| Step | Product | Size | Format | Cap | Function |
|---|---|---|---|---|---|
| 01 | DERMIS//01 CLEANSE | 100 ml | Capsule bottle + lotion pump | Warm graphite matte | Microbiome-balanced gel cleanser |
| 02 | DERMIS//01 ACTIVATE | 120 ml | Capsule bottle + lotion pump | Warm graphite matte | Multi-acid resurfacing toner (AHA·BHA·PHA) |
| 03 | DERMIS//01 SIGNAL | 30 ml | Capsule bottle + lotion pump | Warm graphite matte | Peptide & growth-factor serum |
| 04 | DERMIS//01 BARRIER | 50 ml | Capsule bottle + lotion pump | Warm graphite matte | Ceramide & lipid restoration emulsion |
| 05 | DERMIS//01 SHIELD | 50 g | Capsule jar + screw cap | Warm graphite matte | Mineral SPF 50 PA++++ finishing cream |
Selling a sequenced protocol rather than five separate products is a deliberate commercial play: a system raises average order value, builds a built-in repurchase ladder, and turns the full lineup into a single, photogenic brand object.
The capsule bottle is the commercial centerpiece. Its frosted, thick-base glass shields light-sensitive acids and peptides, while the format is engineered to pair with precision lotion-pump dispensing
SPF is the product most likely to drive daily, habitual repurchase, and it is the clearest signal that DERMIS//01 is a complete morning-to-night clinical system rather than a loose collection of treatments.
The category tailwind is strong: the mineral sunscreen market sits near USD 4.85 billion in 2025 and is forecast to grow at roughly 13% CAGR, with SPF 50+ the fastest-growing sub-segment as “clean” and reef-safe sun care goes mainstream. The foil-sachet format shown here is a sampling and trial-conversion tool — a low-cost way to seed the hero SKU into gift-with-purchase, clinic hand-outs, and travel kits, then convert trial into the full-size jar.
Texture decides dispensing, and dispensing decides packaging. Each DERMIS//01 format is chosen to protect the formula’s performance and the user’s experience: a lotion pump meters the microbiome gel cleanser and the lipid emulsion without waste; a low-dose pump delivers the 30 ml peptide serum drop-accurate; a wide-mouth jar suits the mineral SPF cream’s richer, scoop-and-seal texture. When the container is matched to the rheology of what’s inside, the formula performs as formulated and the ritual feels considered rather than fiddly — a quiet driver of repurchase.
When a brand sells a sequenced routine instead of a single SKU, two things happen: average order value rises, and the customer is structurally guided toward replenishing the whole set rather than one piece. The tray’s molded insert seats each capsule in step order (01→05), so the first experience a buyer has — opening the box — already teaches the ritual.
A rigid-board slide-drawer box presents the complete DERMIS—01 regimen in a custom white tray molded to each piece, with the brand story deboss-printed white-on-white across the interior panel. Primary packaging and secondary packaging share one monochrome language — structure, tray, and finish developed together, in-house. One partner, one contact, from bottle to box.
This is where packaging earns its second job. In content-driven e-commerce, the bottle is the first ad the customer ever sees, and a system engineered to photograph above its production cost compounds every media dollar.
It is also a K-beauty–era advantage: Korea became the No. 2 cosmetics exporter globally in Q1 2025 and overtook France as the top exporter to the U.S., with U.S. K-beauty demand up ~53% year-over-year — a market that rewards exactly this science-forward, visually-disciplined register.
The range is built for a high-intent clinical buyer and a multi-channel rollout:
| Channel | Markets | Hero SKUs |
|---|---|---|
| DTC brand site | US / UK / AU | Full 5-piece set + “Protocol Starter” bundle |
| Dermatology-clinic retail | US / UK / DE | SIGNAL 30 ml + BARRIER 50 ml (post-treatment pair) |
| Sephora / Space NK | US / UK | ACTIVATE 120 ml + CLEANSE 100 ml (hero duo) |
| Amazon Premium Beauty | US | SHIELD 50 g SPF (standalone entry SKU) |
| Tmall International / Xiaohongshu | China | Full set; SIGNAL as KOL hero |
| Travel retail & gifting | Pan-market | Protocol Starter Mini; full set in rigid box |
Because the same five SKUs flex across DTC, clinic, prestige retail, and social commerce, the packaging system has to hold up under medical scrutiny и in a thumbnail. DERMIS//01 is designed to do both — which is what makes a clinical range scalable across markets rather than locked to one.
17-й этаж, Восточная башня, дом 2,
Инновационный центр Yiyun Tech,
№ 33-13, улица Цзиньши Третья, улица Даюань,
Район Байюнь, город Гуанчжоу,
Провинция Гуандун, Китай
Офис 10, 24-й этаж,
Башня-Один,
943 Шейх Зайд Роуд,
Барша Хайтс (Аль Тания Первая),
Дубай, Объединённые Арабские Эмираты
© Copyright 2026 Jarsking Packaging Все права защищены.
